Full Text View
Tabular View
No Study Results Posted
Related Studies
Assessment of Atrophogenic Potential of Triple Combination Cream for Treatment of Melasma
This study has been completed.
Study NCT00469183   Information provided by Galderma Laboratories, L.P.
First Received: May 2, 2007   Last Updated: March 28, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Melasma
Additional conditions recognized in this trial
Melanosis
More general conditions related to this trial
Hyperpigmentation
Pigmentation Disorders
Skin Diseases
Additional drug interventions recognized in this trial
Fluocinolone Acetonide
Hydroquinone
More general drug interventions related to this trial
Anti-Inflammatory Agents
Antioxidants
Glucocorticoids
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Radiation-Protective Agents
Therapeutic Uses
Sponsors listed in this trial
Galderma Laboratories, L.P.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services